Literature DB >> 25141826

Increased and early lipolysis in children with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency during fast.

C Bieneck Haglind1, A Nordenström, S Ask, U von Döbeln, J Gustafsson, M Halldin Stenlid.   

Abstract

Children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD) have a defect in the degradation of long-chain fatty acids and are at risk of hypoketotic hypoglycemia and insufficient energy production as well as accumulation of toxic fatty acid intermediates. Knowledge on substrate metabolism in children with LCHAD deficiency during fasting is limited. Treatment guidelines differ between centers, both as far as length of fasting periods and need for night feeds are concerned. To increase the understanding of fasting intolerance and improve treatment recommendations, children with LCHAD deficiency were investigated with stable isotope technique, microdialysis, and indirect calometry, in order to assess lipolysis and glucose production during 6 h of fasting. We found an early and increased lipolysis and accumulation of long chain acylcarnitines after 4 h of fasting, albeit no patients developed hypoglycemia. The rate of glycerol production, reflecting lipolysis, averaged 7.7 ± 1.6 µmol/kg/min, which is higher compared to that of peers. The rate of glucose production was normal for age; 19.6 ± 3.4 µmol/kg/min (3.5 ± 0.6 mg/kg/min). Resting energy expenditure was also normal, even though the respiratory quotient was increased indicating mainly glucose oxidation. The results show that lipolysis and accumulation of long chain acylcarnitines occurs before hypoglycemia in fasting children with LCHAD, which may indicate more limited fasting tolerance than previously suggested.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25141826     DOI: 10.1007/s10545-014-9750-3

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  46 in total

1.  Insulin sensitivity and lipolysis in adolescent girls with poorly controlled type 1 diabetes: effect of anticholinergic treatment.

Authors:  M U Halldin; K Brismar; T Tuvemo; J Gustafsson
Journal:  Clin Endocrinol (Oxf)       Date:  2002-12       Impact factor: 3.478

2.  Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physicians.

Authors:  Beth K Potter; Julian Little; Pranesh Chakraborty; Jonathan B Kronick; Jessica Evans; Julia Frei; Sarah C Sutherland; Kumanan Wilson; Brenda J Wilson
Journal:  J Inherit Metab Dis       Date:  2011-06-01       Impact factor: 4.982

3.  Growth in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency.

Authors:  C Bieneck Haglind; M Halldin Stenlid; S Ask; J Alm; A Nemeth; Uv Döbeln; A Nordenström
Journal:  JIMD Rep       Date:  2012-07-06

4.  Ophthalmologic findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation: a new type of hereditary metabolic chorioretinopathy.

Authors:  T Tyni; T Kivelä; M Lappi; P Summanen; E Nikoskelainen; H Pihko
Journal:  Ophthalmology       Date:  1998-05       Impact factor: 12.079

5.  Determination of plasma acetoacetate and D-beta-hydroxybutyrate in new-born infants by an enzymatic fluorometric micro-method.

Authors:  B Persson
Journal:  Scand J Clin Lab Invest       Date:  1970-01       Impact factor: 1.713

Review 6.  Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies.

Authors:  Autumn L Fletcher; Mark E Pennesi; Cary O Harding; Richard G Weleber; Melanie B Gillingham
Journal:  Mol Genet Metab       Date:  2012-03-08       Impact factor: 4.797

7.  Dietary management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). A case report and survey.

Authors:  M Gillingham; S Van Calcar; D Ney; J Wolff; C Harding
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

Review 8.  Human fat cell lipolysis: biochemistry, regulation and clinical role.

Authors:  Peter Arner
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2005-12       Impact factor: 4.690

9.  Long-term dietary effects on substrate selection and muscle fiber type in very-long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice.

Authors:  Sara Tucci; Sonja Pearson; Diran Herebian; Ute Spiekerkoetter
Journal:  Biochim Biophys Acta       Date:  2013-01-09

10.  Growth hormone secretory dynamics in subjects with normal stature.

Authors:  G Costin; F R Kaufman; J A Brasel
Journal:  J Pediatr       Date:  1989-10       Impact factor: 4.406

View more
  2 in total

1.  Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD/TFPD.

Authors:  Gabriela Elizondo; Dietrich Matern; Jerry Vockley; Cary O Harding; Melanie B Gillingham
Journal:  Mol Genet Metab       Date:  2020-09-06       Impact factor: 4.797

Review 2.  Role of 3-Hydroxy Fatty Acid-Induced Hepatic Lipotoxicity in Acute Fatty Liver of Pregnancy.

Authors:  Sathish Kumar Natarajan; Jamal A Ibdah
Journal:  Int J Mol Sci       Date:  2018-01-22       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.